Inclusive of all taxes
TELMISIGN AM Tablet by Dr Precision is a high-quality fixed-dose combination medication containing 40 mg Telmisartan and 5 mg Amlodipine, specifically designed for effective management of hypertension. This antihypertensive medication synergistically combines an angiotensin II receptor blocker (Telmisartan) and a calcium channel blocker (Amlodipine) to provide comprehensive 24-hour blood pressure control. Telmisartan works by preventing vasoconstriction through angiotensin II receptor antagonism, while Amlodipine relaxes vascular smooth muscles to reduce cardiac workload and improve blood flow. This dual mechanism effectively lowers elevated blood pressure, reduces cardiovascular risk, and simplifies treatment with once-daily dosing. Manufactured under stringent GMP standards by Bluepill Express and marketed under the trusted Dr Precision label, TELMISIGN AM ensures superior quality, compliance with WHO-GMP and ISO certifications, and reliable therapeutic efficacy. It is ideal for patients inadequately controlled on monotherapy or those requiring combination therapy to enhance adherence and therapeutic outcomes. The product comes packaged in moisture-resistant, tamper-proof strips maintaining stability and efficacy throughout its shelf life. Suitable for use with physician guidance, TELMISIGN AM requires monitoring of renal function and blood pressure during therapy and is contraindicated in pregnancy and hypersensitivity to components. Its reliable formulation reduces risks of heart attack, stroke, and renal complications associated with hypertension.
Key Features
| Features | Description |
|---|---|
| Drug Composition | Telmisartan 40 mg and Amlodipine 5 mg per tablet |
| Mechanism of Action | Telmisartan blocks angiotensin II receptors; Amlodipine is a calcium channel blocker |
| Indication | Management of hypertension and cardiovascular risk reduction |
| Dosage Form | Film-coated tablet for once-daily oral administration |
| Therapeutic Benefit | Provides effective 24-hour blood pressure control with dual antihypertensive action |
| Manufacturing Standards | Produced under WHO-GMP and ISO-certified facility by Bluepill Express |
| Packaging | Moisture-resistant, tamper-proof blister strips |
| Safety Profile | Generally well-tolerated; requires monitoring for renal function and blood pressure |
| Target Patient | Patients inadequately controlled with monotherapy or requiring combination therapy |
| Attributes | Description |
|---|---|
| Active Ingredients | Telmisartan and Amlodipine |
| Strength | Telmisartan 40 mg, Amlodipine 5 mg per tablet |
| Administration Route | Oral |
| Dosage Frequency | Once daily |
| Therapeutic Class | Antihypertensive - ARB and CCB combination |
| Shelf Life | Typically 24 months from manufacturing date |
| Storage Conditions | Store in a cool, dry place away from direct sunlight |
| Packaging Type | Blister packs with moisture-resistant strips |
| Quality Certifications | WHO-GMP, ISO |
| Manufacturer | Bluepill Express under Dr Precision brand |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
TELMISIGN AM Tablet combines Telmisartan's ARB action and Amlodipine's calcium channel blocking effect, providing complementary mechanisms that maintain blood vessel relaxation and reduce cardiac workload throughout the day with once-daily dosing.
Yes, TELMISIGN AM is specifically formulated to assist patients who have inadequate blood pressure control with monotherapy by providing a synergistic dual antihypertensive effect.
The formulation is produced under WHO-GMP and ISO-certified manufacturing processes by Bluepill Express, ensuring high-quality, consistent, and safe medication delivery.
The tablets are packed in moisture-resistant, tamper-proof strips and should be stored in a cool, dry place away from direct sunlight to maintain efficacy and stability.
Caution is advised when prescribing TELMISIGN AM to patients with renal or hepatic dysfunction; close monitoring is recommended as these conditions may affect drug metabolism and safety.
Patients should have regular monitoring of blood pressure, renal function, and electrolyte levels, particularly during long-term therapy, to ensure safety and therapeutic effectiveness.
Country Of Origin: India
TELMISIGN AM Tablet is a combination medication containing Telmisartan and Amlodipine. It is used to effectively manage high blood pressure by relaxing blood vessels and improving blood flow, thereby reducing the risk of heart attack, stroke, and kidney disease.
This product is manufactured under the Dr Precision label, ensuring GMP-compliant quality and precision formulation standards.
TELMISIGN AM Tablet is a fixed-dose combination of two antihypertensive agents, Telmisartan and Amlodipine, formulated to provide dual-action control over blood pressure. Telmisartan belongs to the angiotensin II receptor blocker (ARB) class, while Amlodipine is a calcium channel blocker (CCB). Together, they work synergistically to lower elevated blood pressure more effectively than either agent alone.
Telmisartan helps by blocking the action of angiotensin II, a chemical that causes blood vessels to constrict. By inhibiting this action, it relaxes and widens blood vessels, allowing for smoother blood flow and reduced vascular resistance. Amlodipine works by relaxing the muscles of the heart and blood vessels, thereby reducing the workload on the heart and helping to prevent chest pain and arrhythmias associated with high blood pressure.
TELMISIGN AM is particularly beneficial for patients whose blood pressure is not adequately controlled with monotherapy. It is also useful in cases where combination therapy can help lower cardiovascular risk and improve adherence by simplifying treatment into a single daily dose. The once-daily dosing ensures 24-hour control of blood pressure and helps prevent fluctuations that can lead to cardiovascular events.
The combination is generally well-tolerated, though some patients may experience mild side effects such as dizziness, swelling of the ankles or feet, headache, or fatigue during the initiation of therapy. Serious adverse reactions are rare but may include hypotension, renal dysfunction, or allergic reactions. Regular monitoring of blood pressure, renal function, and electrolyte levels is recommended, especially during long-term use.
TELMISIGN AM should not be used during pregnancy or by individuals with known hypersensitivity to any of its components. Caution should be exercised in patients with liver or kidney disease. It is also advisable to consult a healthcare professional before starting therapy, especially for individuals on other medications for cardiovascular or renal conditions.
Manufactured under the strict quality control standards of Bluepill Express, TELMISIGN AM Tablet meets international regulatory and manufacturing norms, including WHO-GMP and ISO certifications. Each batch undergoes rigorous quality assurance tests, including stability analysis, dissolution profiling, impurity checks, and microbial load assessment. The product is packaged in moisture-resistant, tamper-proof strips to ensure optimal stability and shelf life.
Inclusive of all taxes
You Save: 0
Surat , India
Manufacturer, Contractor, Retailer, Brand Owner, Distributor, Exporter, Importer, Wholesaler, Startup
GST- 24abdfb4194j1ze
